Skip to main content

Closed

VERU: Veru Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-49.5%

Financially safe

Stretched

Debt / equity0.08×

Interest coverage0.0×

Current ratio6.19×

Veru Inc.

VERUNASDAQ Capital Market·USD·Closed

Veru Inc.

VERUNASDAQ·USD·Closed

$2.24

+0.90%

$2.24

+$0.02 (0.90%)

52W Range

4thpctl

Volume

0.08×avg

Mkt Cap

35.95MUSD

P/E

-2.8TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.08×avg

Market Cap

35.95MUSD

P/E Ratio

-2.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings